🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Poly(ADP-ribose) polymerase (PARP) inhibitors are anti-cancer treatments th...
Status
Recruiting
Location
Centre Hospitalier Universitaire d'Amiens Picardie Site Sud
Start Date
2024-09-24
Trial ID
NCT06572735
Treatments Being Tested
Colorectal Cancer ranks third among the most frequent malignancies represen...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-09-04
Trial ID
NCT05412706
Treatments Being Tested
Background: High-grade serous epithelial ovarian cancer is a disease with a...
Status
Recruiting
Location
CHU de Nîmes
Start Date
2020-10-01
Trial ID
NCT06827353
Treatments Being Tested
This study will determine whether MK-4827 can be safely administered in com...
Status
Terminated
Location
Multiple Locations
Start Date
2010-11
Trial ID
NCT01227941
Treatments Being Tested
This is an open-label, multi-center Phase 0 study with an expansion phase t...
Status
Active Not Recruiting
Location
St. Joseph's Hospital and Medical Center
Start Date
2021-10-29
Trial ID
NCT05076513
Treatments Being Tested
This study aims to assess efficacy of Niraparib (GSK3985771) as maintenance...
Status
Active Not Recruiting
Location
GSK Investigational Site
Start Date
2016-07-11
Trial ID
NCT02655016
Patients will be registered prior to, during or at the completion of neoadj...
Status
Recruiting
Location
City of Hope
Start Date
2024-03-08
Trial ID
NCT05659381
Treatments Being Tested
This is a single-center, prospective, single-arm clinical trial to evaluate...
Status
Unknown
Location
Multiple Locations
Start Date
2023-05
Trial ID
NCT05749211
Treatments Being Tested
Ovarian cancer is a heterogeneous disease, characterized by complex molecul...
Status
Active Not Recruiting
Location
GSK Investigational Site
Start Date
2018-10-11
Trial ID
NCT03602859
Treatments Being Tested
This phase II trial studies the effect of cabazitaxel, carboplatin, and cet...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2020-12-29
Trial ID
NCT04592237
Treatments Being Tested